<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04932343</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 2019-07-101</org_study_id>
    <nct_id>NCT04932343</nct_id>
  </id_info>
  <brief_title>Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic Tumor</brief_title>
  <official_title>Comparison of Genomic and Transcriptomic Patterns Between the Circulating Tumor Cells and Metastatic Tumor Cells, and Their Specific Relevance to Circulating Tumor DNAs: Quest for Any Distinct or Complementary Roles of CTCs and ctDNAs to Understand the Metastasis in Advanced NSCLC</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CytoGen, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>UNIST (Ulsan National Institute of Science and Technology)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to understand the metastasis in advanced NSCLC through comparing genomic and&#xD;
      transcriptomic patterns between the circulating tumor cells and metastatic tumor cells by&#xD;
      single cell sequencing analysis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The gene expression and the cell population</measure>
    <time_frame>3 year</time_frame>
    <description>Methods for the single cell RNA sequencing and whole exome sequencing of the tumor cells With the tissue biopsied specimens, scRNAseq (by 10X Genomics platform) and whole exome seq will be carried out.</description>
  </primary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>NSCLC Stage IV</condition>
  <condition>NSCLC Stage IIIB</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>cohort study</intervention_name>
    <description>no intervention</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Treatment naïve stage III-IV non-small cell lung cancer who undergoing surgery for any&#xD;
        intent&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All subjects need to sign the informed consent form&#xD;
&#xD;
          -  All subjects have non-small cell lung cancer which suspected on chest CT or confirmed&#xD;
             pathologically preoperatively&#xD;
&#xD;
          -  Treatment naïve advanced lung cancer (including extensive stage IIIb and stage IV)&#xD;
&#xD;
          -  Patients who were suitable to provide enough metastatic tumor tissue and blood (30ml)&#xD;
             for the single cells sequencing&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with previous history of lung cancer&#xD;
&#xD;
          -  Have been undergone chemotherapy or radiotherapy due to non-small call lung cancer&#xD;
&#xD;
          -  Have been diagnosed any type of cancer other than cancer of skin, thyroid, uterine&#xD;
             cervix within 5 years before enrollment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jhingook Kim, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 13, 2021</study_first_submitted>
  <study_first_submitted_qc>June 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2021</study_first_posted>
  <last_update_submitted>June 18, 2021</last_update_submitted>
  <last_update_submitted_qc>June 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Jhingook Kim, MD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

